Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02244515

Enrollment

Registered

2014-09-19

Start date

2014-06-30

Completion date

Unknown

Last updated

2014-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Deliruim; Cerebral Palsy

Keywords

children

Brief summary

The purpose of this study is to determine whether dexmedetomidine is effective in the treatment of emergence deliruim after sevoflurane anesthesia in children with cerebral palsy.

Interventions

DRUGdexmedetomidine

dexmedetomidine 0.5μg•kg-1 diluted in 10 ml NaCI 0.9%

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

2 Years to 12 Years

Healthy volunteers

Inclusion criteria

Non-quadriplegic (mono-,di-, hemiplegic) children with CP that are scheduled for elective Achilles-tendon lengthening procedure Guangzhou Women and Children's Medical Center, Guangzhou, China, with American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion criteria

Participants that displayed symptoms of sinus bradycardia and atrio-ventricular block, non-communicative severe developmental delay, seizure disorders, and treatment with seizure medications

Design outcomes

Primary

Measure	Time frame
pediatric anesthesia emergence delirium (PAED) scale	during stay in postanesthesia care unit
Heart rate	during surgical procedures
systolic blood pressure	during surgical procedures
diastolic blood pressure	during surgical procedures

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026